Ell, P.
Martin, J. M.
Cehic, D. A.
Ngo, D. T. M
Sverdlov, A. L. http://orcid.org/0000-0003-2539-8038
Funding for this research was provided by:
National Heart Foundation of Australia (101918, 104814)
NSW Ministry of Health (Cardiovascular Capacity Building Program, EMCR Fellowship)
Hunter Cancer Research Alliance (New Strategic Initiatives Grant)
John Hunter Charitable Trust (Project Grant)
Article History
Accepted: 30 April 2021
First Online: 10 June 2021
Compliance with Ethical Standards
:
: Philippa Ell declares that she has no conflict of interest. Jarad Martin is a contractor and shareholder for GenesisCare. Daniel A. Cehic declares that he has no conflict of interest. Doan T.M. Ngo declares that she has no conflict of interest. Aaron L. Sverdlov has received an equipment loan for research support from Roche Diagnostics Pty Ltd., an unrestricted educational grant from Celgene Pty Ltd., and a conference sponsorship grant from Bristol-Myers Squibb Australia Pty Ltd.